GLP-1 drugs and weight loss: separating TikTok hype from trial data

What did @skincureuk actually say?

Straightforwardly: nothing about GLP-1 medications, weight loss, or health. The video tagged under the GLP-1 category contains only song lyrics. The transcript reads, "Show me that no, we know my name / Don't mean nobody, just need your body / Show me that no, so it's me like honey / Don't mean no talking, just need your body." There are no medical claims here. None. This appears to be a lifestyle or fashion post that was categorized as GLP-1 content, possibly due to platform tagging or creator account association rather than actual video content.

The hashtags used, including "fashion," "you," and "onthisday," do not reference semaglutide, tirzepatide, or any GLP-1 receptor agonist. The account handle @skincureuk suggests a skincare or aesthetics focus, which may explain why the video surfaced in a health-adjacent monitoring sweep. But the content itself gives us nothing to fact-check in terms of pharmacology or treatment claims.

Does the science back this up?

There is no scientific claim in this video to evaluate. The lyrics reference wanting someone's body in a romantic context, which is not a pharmacological assertion. No dosing information, no mechanism of action, no anecdotal weight loss result, no before-and-after framing. Since we cannot fact-check silence on a topic, we can only note what the science actually says about GLP-1 medications for context.

GLP-1 receptor agonists like semaglutide have a substantial evidence base. The STEP 1 trial (Wilding et al., 2021, New England Journal of Medicine) found that weekly 2.4mg semaglutide produced a mean body weight reduction of 14.9% over 68 weeks in adults with obesity. Tirzepatide data from the SURMOUNT-1 trial (Jastreboff et al., 2022, NEJM) showed up to 22.5% weight reduction at the highest dose. These are real, peer-reviewed findings. They just have nothing to do with this video.

What did they get wrong (or right)?

This is genuinely difficult to assess because the creator made no factual statements. They cannot be credited with accuracy they did not attempt, and they cannot be penalized for errors they did not make. What we can flag is the mismatch between the content and its categorization. A video consisting entirely of song lyrics should not be reviewed as a health information source, and consumers finding this video through a GLP-1 content search would get zero useful information from it.

If anything, the absence of medical claims is preferable to the alternative. Social media is full of accounts making unsupported assertions about GLP-1 medications, including false claims about compounded semaglutide being equivalent to branded Wegovy or Ozempic, or suggesting these medications cure metabolic disease rather than manage it. @skincureuk did none of that here. The video is medically inert, which in this space is not the worst outcome.

What should you actually know?

If you landed here looking for GLP-1 information, here is what actually matters. Semaglutide and tirzepatide are prescription-only medications in the UK, regulated by the MHRA. They are not appropriate for self-prescribing, and dosing decisions should be made with a qualified prescriber who has reviewed your full medical history.

Key things to understand before starting any GLP-1 therapy include the difference between licensed brand-name products and compounded versions, since these are not interchangeable under UK or US regulatory frameworks. The FDA and MHRA have both issued warnings about compounded semaglutide products. Side effects, including nausea, vomiting, and rare but serious risks like pancreatitis, require clinical monitoring. A TikTok video, including this one, is not a substitute for that conversation.

• Always verify that a telehealth platform is CQC-registered (UK) or operates under appropriate state medical board oversight (US) before obtaining a prescription.
• Ask your prescriber specifically whether you are receiving a licensed product or a compounded formulation, as these carry different regulatory statuses.